-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO NORDISK CSO: WE BELIEVE NEXTGEN GLP-1 TO BE POTENTIALLY DIFFERENTIATED ACROSS EFFICACY, CONVENIENCE, SAFETY, TOLERABILITY

路透·09/21/2026 10:03:24

登录查看新闻详情